Humic and Fulvic Acid Supplement for Biological Aging and Detoxification Markers
Official title: Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress
Run by OvationLab · NCT07579845 · Data updated 2026-11-12
This study tests BioToxin Binder, a humic and fulvic acid supplement, to see if it affects aging, detoxification, inflammation, and oxidative stress markers in generally healthy adults aged 40 and older.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | OvationLab Research network |
| Locations | 1 site (Richmond, Virginia) |
| Status | Recruiting |
| Started | May 5, 2026 |
| Main results expected | September 2026 |
| Study ends | September 2026 |
| Registry record updated | May 29, 2026 |
| Trial ID | NCT07579845 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 40 years and older who can read and speak English and are not using other humic/fulvic acid or binder supplements.
✕Probably not a fit
Individuals with certain health conditions or those taking specific binder supplements may not experience benefits or could be excluded from the study for safety reasons.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study will administer BioToxin Binder, a dietary supplement containing humic and fulvic acid, to adults 40 years and older. The goal is to observe changes in markers of biological age, detoxification capacity, inflammation, and oxidative stress. Participants will be screened for eligibility and monitored for safety and biomarker changes during the study period. The study is conducted at OvationLab in Richmond, VA, with English-speaking participants only. No collaborators are listed beyond the sponsor.
Why it matters
Potential benefit: If successful, the study could provide evidence on whether this supplement influences aging-related biomarkers and detoxification/inflammatory processes.
How similar studies have gone: Previous work on humic/fulvic acid supplements has shown mixed results; this study aims to add targeted biomarker data in a healthy population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult females or males age ≥ 40 years 2. Ability to read and speak English Exclusion Criteria: 1. Current use of a dietary supplement containing fulvic or humic acid 2. Current use of other binder dietary supplements, including activated charcoal, modified citrus pectin, bentonite clay, or chlorella 3. Known allergies to any ingredients in the product 4. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks 5. Current diagnosis of a chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol 6. Participants unable to provide consent
Where it's running
-
OvationLab
Richmond, Virginia, United States Recruiting
Study contacts
- Study coordinator: Study Administrator
- Email: info@ovationlab.com
- Phone: (240) 232-2103
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can CBD help with alcohol withdrawal and craving
This study tests whether cannabidiol (CBD) given with standard care can reduce withdrawal symptoms and craving in adults with moderate-to-severe alcohol use disorder during a short inpatient withdrawal period.
-
A platform for researching healthy aging and biomarkers
This study is trying to find out how we can spot signs of aging and age-related diseases by collecting health information from people aged 30 and older over ten years.
-
Predicting Heart Muscle Recovery After CTO Revascularization
This study looks at whether blood tests and stress echo measurements can predict which patients with CTO will regain heart muscle function after a revascularization procedure.
-
Collagen and omega-3 supplements in middle-aged women
This study tests whether taking collagen and omega-3s together improves joint pain, fatigue, sleep, and overall wellbeing in healthy women aged 35–65 compared with a placebo over 8 weeks.
-
Creatine or placebo to test effects on cognition, muscle strength, and body composition in middle-aged women
This study tests whether taking creatine daily for 8 weeks improves thinking, strength, fatigue, and body composition in healthy middle-aged women compared to a placebo.
-
How common dietary fats change gut bacteria and metabolic markers
We will test whether replacing part of daily fat with butter, coconut oil, olive oil, or sunflower oil for two weeks changes gut bacteria and related blood markers in healthy adults aged 20–50.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.